Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Trevena Inc.
DescriptionSmall molecule G protein biased ligand targeting opioid receptor delta 1 (OPRD1; DOR)
Molecular Target Opioid receptor delta 1 (OPRD1) (DOR)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationMigraine
Indication DetailsTreat refractory migraine
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today